SAC Capital Roasted In Investigation Of Heavy Weight Watchers Trades

SAC Capital Roasted In Investigation Of Heavy Weight Watchers Trades
See page for author [Public domain], via Wikimedia Commons

SAC Capital Roasted In Investigation Of Heavy Weight Watchers Trades

SAC Capital Advisers, which is headed up by reputable investor and billionaire, Steven A. Cohen, is being investigated for possible insider trading involving shares of Weight Watchers International, Inc. (NYSE:WTW) and InterMune, Inc. (NASDAQ:ITMN). Reuters first reported the investigation regarding the Weight Watchers trades, citing an anonymous source familiar with the investigation, who said Cohen himself could be implicated in the investigation. Bloomberg added InterMune, Inc. (NASDAQ:ITMN) to the report early this morning.

The investigation into the Weight Watchers shares involves trades that took place in 2011, when the hedge fund had significant holdings in the company. At that time SAC Capital held more than 2 million shares of Weight Watchers International, Inc. (NYSE:WTW), and the price of those shares doubled during that time frame.

Seth Klarman Describes His Approach In Rare Harvard Interview

Seth KlarmanIn a rare interview with Harvard Business School that was published online earlier this month, (it has since been taken down) value investor Seth Klarman spoke at length about his investment process, philosophy and the changes value investors have had to overcome during the past decade. Klarman’s hedge fund, the Boston-based Baupost has one of Read More

In the quarter before SAC Capital increased its holdings in Weight Watchers significantly, the hedge fund held less than 80,000 shares. The weight loss company’s stock rose significantly after it forecast full-year earnings over the estimates of analysts. Then, SAC Capital decreased its holdings to less than 80,000 shares at the end of June, right before it dropped significantly in early August, as the company reported higher spending on technology and advertising in the second quarter.

The trades of InterMune, Inc. (NASDAQ:ITMN) that have been called into question, took place in the first quarter of 2010 when SAC Capital purchased almost 2 million shares of the stock, after holding no position in it for the two quarters prior. By the end of the second quarter of 2010, the hedge fund held fewer than 11,000 shares of the stock. Shares of InterMune increased significantly in early March after a favorable drug trial review. However, after regulators rejected the company’s application for a lung treatment, the stock fell.

Neither Cohen himself nor SAC Capital has officially been accused of any wrongdoing in these investigations. SAC Capital told Reuters it was unaware of an investigation involving shares of Weight Watchers International, Inc. (NYSE:WTW).  Representatives of Manhattan’s U.S. attorney’s office and Weight Watchers have not commented on the investigation, which is the latest in a series of probes involving SAC Capital.

Late last month, prosecutors charged trader Mathew Martoma, a former portfolio manager at SAC Capital, with insider trading in connection with trades which took place shortly before a negative drug trial was revealed, causing shares of Wyeth, now a subsidiary of Pfizer Inc. (NYSE:PFE) and Elan Corporation, plc (NYSE:ELN) to drop significantly. Martoma is SAC Capital’s seventh employee to face federal charges of insider trading.

Updated on

Michelle Jones is editor-in-chief for and has been with the site since 2012. Previously, she was a television news producer for eight years. She produced the morning news programs for the NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spent a short time at the CBS affiliate in Huntsville. She has experience as a writer and public relations expert for a wide variety of businesses. Email her at
Previous article AIG To Sell Its Plane Leasing Business To Chinese Group
Next article Ingersoll-Rand To Spin Off Security Business As Peltz Wins Round One

No posts to display